Harbour Investments’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$874K Buy
23,784
+17,280
+266% +$819K 0.01% 816
2025
Q4
$331K Sell
6,504
-1,587
-20% -$81.2K 0.01% 1038
2025
Q3
$449K Sell
8,091
-46
-0.6% -$2.69K 0.01% 867
2025
Q2
$562K Sell
8,137
-889
-10% -$60.5K 0.01% 733
2025
Q1
$627K Buy
9,026
+12
+0.1% +$991 0.02% 640
2024
Q4
$775K Sell
9,014
-2,118
-19% -$229K 0.02% 553
2024
Q3
$1.33M Sell
11,132
-587
-5% -$78.3K 0.04% 385
2024
Q2
$1.67M Buy
11,719
+3,188
+37% +$422K 0.06% 286
2024
Q1
$1.1M Buy
8,531
+776
+10% +$92.4K 0.04% 392
2023
Q4
$802K Buy
7,755
+1,199
+18% +$119K 0.03% 415
2023
Q3
$596K Sell
6,556
-2
-0% -$176 0.03% 440
2023
Q2
$531K Buy
6,558
+38
+0.6% +$3.1K 0.03% 478
2023
Q1
$519K Buy
6,520
+100
+2% +$7.09K 0.03% 459
2022
Q4
$434K Buy
6,420
+3,632
+130% +$213K 0.03% 492
2022
Q3
$155K Hold
2,788
0.01% 796
2022
Q2
$155K Buy
+2,788
New +$155K 0.01% 796
2021
Q4
$400K Sell
7,146
-7,880
-52% -$427K 0.02% 486
2021
Q3
$721K Buy
15,026
+1,368
+10% +$66.1K 0.02% 525
2021
Q2
$572K Buy
13,658
+8,688
+175% +$337K 0.02% 621
2021
Q1
$168K Buy
+4,970
New +$177K 0.01% 1053

Other funds holding NVO

Harbour Investments's NVO Position: Q1 2026 in Review

Harbour Investments increased its Novo Nordisk (NVO) stake by 266% in Q1 2026, buying an estimated $819K and bringing the position to 23,784 shares worth $874K. The position accounts for 0.01% of the portfolio, ranked #816.

Harbour Investments first reported a position in NVO in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.67M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Harbour Investments held 23,784 shares of Novo Nordisk worth $874K as of Q1 2026.
  • Harbour Investments bought 17,280 Novo Nordisk shares in Q1 2026, an estimated $819K.
  • Novo Nordisk made up 0.01% of Harbour Investments's portfolio in Q1 2026, its #816 holding.
  • Harbour Investments first reported a position in Novo Nordisk in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's Novo Nordisk position peaked at $1.67M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.